Ingigerður Sverrisdóttir

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

Þórir Einarsson Long, Ólafur S. Indridason, Runólfur Pálsson et al. · Blood Cancer Journal · 2022 · 117 citations · Full text

Medicine, Nephrology, Renal Pathology +16

Fractures and survival in multiple myeloma: results from a population-based study

Sigrún Þorsteinsdóttir, Thor Aspelund, Ingigerður Sverrisdóttir et al. · Haematologica · 2019 · 65 citations · Full text

Medicine, Biostatistics, Oncology +14

Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study

Aðalbjörg Ýr Sigurbergsdóttir, Sæmundur Rögnvaldsson, Sigrún Þorsteinsdóttir et al. · Haematologica · 2023 · 39 citations · Full text

Medicine, Hematology, Internal Medicine +15

Comorbidities in multiple myeloma and implications on survival: A population‐based study

Ingigerður Sverrisdóttir, Sölvi Rögnvaldsson, Sigrún Þorsteinsdóttir et al. · European Journal Of Haematology · 2021 · 35 citations

Medicine, Oncology, Epidemiology +16

Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden

Kari Lenita Falck Moore, Ingemar Turesson, Anna Genell et al. · Haematologica · 2022 · 29 citations · Full text

Medicine, Hematology, Pharmacotherapy +14